Showing results (521-530 of 2,158) with videos related to
Sort By:
Pageof 216
Journal of Biopharmaceutical Statistics|August 19, 2003
A quantitative assessment of factors influencing the probability of postmarketing out-of-specification observationsWilliam R FairweatherJournal of Biopharmaceutical Statistics|August 19, 2003
A note on kinetic modeling of stability data and implications on poolingStan Altan, Damaraju RaghavaraoJournal of Biopharmaceutical Statistics|August 19, 2003
On non-inferiority analysis based on delta-method confidence intervalsMark D Rothmann, Hsiao-Hui TsouJournal of Biopharmaceutical Statistics|January 1, 1992
Statistical comparison of stability study designsE NordbrockJournal of Biopharmaceutical Statistics|January 1, 1992
Alternative approaches to the analysis of binary and categorical repeated measurementsM G Kenward, B JonesJournal of Biopharmaceutical Statistics|January 1, 1992
Demonstration of the reproducibility of treatment efficacy from a single multicenter trialW J Huster, W C LouvJournal of Biopharmaceutical Statistics|November 9, 2010
Perspectives on the use of adaptive designs in clinical trials. Part I. Statistical considerations and issuesSue-Jane WangJournal of Biopharmaceutical Statistics|November 9, 2010
Viewpoints on the FDA draft adaptive designs guidance from the PhRMA working groupPaul Gallo, Keaven Anderson, Christy Chuang-Stein, et al.Journal of Biopharmaceutical Statistics|November 9, 2010
Review of draft FDA adaptive design guidanceThomas Cook, David L DeMetsJournal of Biopharmaceutical Statistics|November 9, 2010
Adaptive methods: telling "the rest of the story"Scott S Emerson, Thomas R FlemingPageof 216